Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Easy double by New Year's 2022

<< Previous

Bullboard Posts

Next >>

Post by newdaydawningon Jan 05, 2021 5:32pm

274 Views

Post# 32229201

Easy double by New Year's 2022

If the Canadian NMIBC numbers come in as expected, the US trial sites begin treatments, and the anti-viral COVID-19 treatment gets funded by Ottawa, TLT should easily be able to capture the value it possessed just one short year ago.

THAT's AN EASY DOUBLE - or plenty more - FROM HERE TILL NEXT YEAR!!!!

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo